Echo IQ is trading 5.41% down at A$0.53 now; the available evidence does not establish a specific cause for the decline.

  • The latest company announcement, released October 12, concerned its EchoSolv HF FDA 510(k) appeal.
  • The FDA accepted the administrative appeal after its initial “Not Substantially Equivalent” determination.
  • Sources do not say the announcement drove the share-price drop.